MARLENE DABESTAN: Open Payments
NPI 1831828474 · TALENT, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 12 payments from 7 companies in 2025. Trend: 2023 $124 · 2024 $258 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $202 |
| Novo Nordisk Inc | 3 | $59 |
| Astellas Pharma US Inc | 1 | $28 |
| Lundbeck LLC | 1 | $28 |
| Exact Sciences Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: CREON, Wegovy, QULIPTA, Veozah, REXULTI, Cologuard Collection Kit, UBRELVY, Ozempic.
Industry payments across OR — which companies pay providers there.
